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1. Introduction 
Fluorinated pyrimidines and their nucleosides are 
widely used in the chemotherapy of tumors; their 
mode of action requires the formation of nucleotide 
derivatives (summa~ [I ] ). Uridine kinase 
(EC 2.7.1.48) plays a key role in the conversion of 
5fluorouridine (5-FUrd) to its active metabolites. 
The feedback regulation of uridine kinase by UTP 
[2] can be used for an increase in the cell-specific 
uptake of some pyrimidine analogs after depletion 
of the cellular UTP pools [3] . Induction of selective 
UTP deficiency by D-galactosamine (GalN) and 
6azauridine (6aza-Urd) in hepatoma cells [4] is 
associated with an increased formation of phosphoryl- 
ated derivatives of 5-FUrd [3]. This approach [3] has 
the following implications: 
(i) Considerable selectivity for hepatoma cells and 
hepatocytes is based on the action of GalN [3,5] ; 
(ii) The increased activity of uridine kinase [6,7] 
and the high rate of de nova pyrimidine nucleo- 
tide synthesis in hepatoma cells relative to liver 
[7-IO] makes these malignant cells more sus- 
ceptible to the action of 6aza-Urd. 
(iii) The formation and accumulation of 5-fluoxo- 
UDP-amino sugars may serve as a metabolic 
store providing 5-FUrd phosphates; the latter 
become available in amino sugar transferase 
reactions or upon hydroly tic splitting of the fluor- 
inated amino sugar nucieotide. 
In this communication we demonstrate the 
negative correlation between 5-FUrd uptake and 
intracellular UTP level. The replenishment of 
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depleted UTP pools with 5-fluoro-UTP (FUTP) is 
associated with an increased incorporation of 
5-fluorouridylate into RNA. The analysis of S-FUrd 
metabolites formed in the presence of GalN has 
revealed for the first time a formation and accumula- 
tion of 5-~uoro-UDP-hexos~ines and S-~uoro-UDP- 
~-acetylhexos~ines. 
2. Materials and methods 
D-Galactosamine.HCl (GalN) was purchased from 
C. Roth, Karlsruhe. 5-Fluorouridine (5-FUrd) and 
6-azauridine (6-aza-Urd) were obtained from Cal- 
biochem, San Diego.N-(Phosphonacetyl)-L-aspartate 
(PALA) was a generous gift from Dr G. Stark, Depart- 
ment of Biochemistry, School of Medicine, Stanford 
University. 5-Fluoro-[2-“4C]orotic acid, from ICN 
Pharmaceut., Irvine, served as precursor in the 
enzymatic synthesis of 5-fluoro-[2-r4C]uridylate 
[l l] ; 5-F[2-r4C]Urd was prepared by subsequent 
treatment with alkaline phosphatase and isolated by 
paper chromatography in a final purity of >99%. The 
other substrates and enzymes were from Boehringer 
Mannheim, Mannheim. 
2.2. Iracubadion of ascites hepatoma cells 
The transplantable ascites hepatoma AS30D [ 121 
was carried in female Spra~e-Dawley rats. Transplant 
generations 500-530 were used in the present study. 
The tumor cells were collected and incubated as in 
[ 131 except phosphate and sodium bicarbonate in 
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the medium that were changed to 2 mmol/l and 
25 mmol/l, respectively. Initial antipyrimidines in 
the incubation medium were 0.5 tnmol/l for GalN, 
0.2 mmol/l for 6-aza-Urd, 0.8 mmol/l for PALA, 
and 0.23 mmol/l for 5-FUrd. In experiments with 
5-F[2-14C]Urd spec. act. 1.2 Ci/mol was employed. 
2.3. Measurement of .5-jluoro-[‘4CJuridine uptake 
and paper chromatography of its nucleotide 
derivatives 
GalN, 6-aza-Urd, PALA or combinations of these 
compounds were included in the suspension after a 
40 min preincubation of the cells. Incubation in the 
presence of these inhibitors had lasted for 180 min 
when 5-F[2-14C]Urd was added. S-F[14C]Urd uptake 
was terminated by mixing of 1 ml radioactive cell 
suspension with 10 ml unlabeled AS-30D cell suspen- 
sion containing uridine (10 mmol/l) and kept at 4°C. 
Cell pellets were obtained without delay by centri- 
fugation at 4°C and subsequently dissolved in a 
liquid scintillation mixture composed of Triton 
X-100, an equal vol. toluene, POPOP (200 mg/ml), 
and PPO (2 g/l). Counting efficiency was 90%. 
Acid-soluble supernatants were obtained after 
freezing of the cells as in [13] . Supernatants from 
cells labeled for 90 min in the presence of 5-F[2-14C] - 
Urd were spotted on Whatman 3 MM paper and 
chromatographed with the solvent ethanol/ammonium 
acetate (1 tnol/l, pH 7.5) (S/2). 14C-Labeled metab- 
olites were localized by cutting 1 cm sections of the 
paper strips perpendicular to the direction of migra- 
tion and counting at 70% efficiency in 10 ml toluene 
liquid scintillation mixture. 
3. Results 
3.1. Injluence of’ UTP level on the phosphorylation 
of 5-fluoro-uridine in hepatoma cells 
Different UTP levels in ascites hepatoma cells were 
adjusted by incubation of the cells in the presence 
of: (a) GalN that lowers the UTP concentration by 
its uridylate trapping action [4,5] ; (b) PALA, a 
powerful inhibitor of aspartate carbamoyltransferase 
[ 14,151 , causing a depression of cellular UTP levels 
in vitro [ 15,161 ; (c) 6-aza-Urd that leads to an inhibi- 
tion or orotidylate decarboxylase [ 171 and lowers 
the cellular UTP content in vitro [4] ; (d) GalN 
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Fig.1. Contents of UTP and FUTP in hepatoma cells. AS-30D 
cells were incubated as in section 2.2. The preincubation in the 
presence of 6-aza-Urd (0.2 mmol/l), alone or in combination 
with GalN (0.5 mmol/l), lasted for 180 min when 5-FUrd 
(0.23 mmol/l) was added. The sum of UTP + FUTP ((F)UTP) 
was measured cnzymatically [21] ; 5-fluorouridine 5’-phos- 
phates react, although at a lower rate, in this enzymatic 
sequence. The increase induced by 5-FUrd reflects exclusively 
FUTP in cells in which de novo pyrimidinc synthesis has been 
blocked by 6-aza-Urd. Mean values from 4 experiments, 
vertical bars indicate SEM. 
together with PALA [ 161 or 6-aza-Urd [4,10] , both 
combinations leading to a depletion of UTP pools 
in vitro and in vivo. Incubation of AS-30D cells in 
the presence of these inhibitors for3 h asin section 2.2. 
resulted in the following average UTP contents 
relative to control cells (100%): GalN, 60%; PALA, 
45%; 6-aza-Urd, 24%; GalN + PALA, 7%; GalN + 
6-aza-Urd, 5% (fig.1) [4,16] . The corresponding 
factors of increase in uptake of labeled 5-FUrd 
during 15 min relative to control cells (1 .O) were 1.5 
in cells treated with GalN, 2.5 with 6-aza-Urd, 3.1 
with PALA, 3.3 with GalN + 6-aza-Urd, and 4.3 
with GatN + PALA (fig.2). 
Paper chromatography of the acid-soluble metab- 
olites of 5-F [ t4C] Urd indicated that >93% were 
phosphorylated derivatives when the UTP pool had 
been reduced below 10% before the addition of 
5-FUrd. Induction of selective UTP deficiency [4] 
followed by addition of 5-FUrd resulted in a replenish- 
ment of the cellular UTP pool with FUTP (fig.1). 
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Fig.2. Uptake of S-fluoro-[ “C] uridine into hepatoma cells 
pretreated with antipyrimidines. AS-30D cells were incubated 
at 37°C at 1.8-2.3 X lo9 cells/l. The pH was kept between 
7.45 and 7.25. For further details see sections 2.2. and 2.3. 
The radioactivities per sample ranged from 500-18 000 cpm. 
Mean values obtained from 6 experiments, vertical bars 
indicate i SEM that was consistently <11% of the mean. 
However, the level of FUTP t UTP remained lower in 
the presence of GalN (fig.1). This contributes to an 
increased uptake of S-FUrd into the cells since FUTP 
serves as feedback inhibitor of uridine kinase as well 
121. PALA supported the uptake of 5-FUrd better 
than 6aza-Urd (fig.2). This was not due to a smaller 
depression of the UTP content by the 6-aza analog 
of uridine but may be related to an interference of 
6-aza-Urd or its metabolite 6-aza-UMP with transport 
or phosphorylation of S-FUrd, 
3.2. Formation of S-fluorountdine d~phosp~ate amino 
sugars in the presence of D-galactosamine 
The formation [ 181 and accumulation [ 191 of 
UDP-galactosamine and UDP-glucosamine (UDP- 
HexN) and of UDP-~-acetylglucosamine and UDP- 
~-acetylgalactosamine {UDPHex~Ac) as metabolites 
of GalN has been described in liver and hepatoma 
cells [4,5,10]. Labelling of these amino sugar nucleo- 
tides with 5-F[2-14C]Urd has now established the 
formation and accumulation of FUDP-HexN and 
FOP-HexNAc (fig.3). Both fractions could also be 
labeled from [ “C]GalN and comigrated upon paper 
0 
s 0 
x 
T 0 10 
F 
20 30 10 
DISTANCE FROM ORIGIN (cm) 
Fig.3. Radio-paper chromatography of acid-soluble extracts 
of AS30D ceils labeled with S-F[ ‘Y]Urd. Cells were 
incubated and treated as in section 2.2. and 2.3. Equal 
sample volumes, corresponding to 36 mg cells, were spotted 
on the paper. The pattern of fluorouracil nucleotides obtained 
after CalN treatment, in the presence or absence of 6-aza-Urd 
or PALA, was characterized by an accumulation of FUDP- 
HexN and a substantial increase in FUDP-HexNAc. Similar 
nucleotide patterns were observed in 4 different experiments 
performed under the same conditions. 
chromatography with UDP-[r4C]GalN and UDP- 
[ 14C] GalNAc, respectively. Both fractions were 
resistant to treatment with alkaline phosphatase and 
yielded [‘“Cl FUMP upon hydrolysis with snake 
venom phosphodiesterase; the FUMP formed was 
assayed enzymatically [20] . Acid hydrolysis in HCI 
(0.1 mol/l) for 20 min at 95°C liberated [ 14C] FUDP 
(80%) and [ “C]FUMP (20%) from FUDP-HexNAc 
but was insufficient to hydrolyze FUDP-HexN. The 
amount of FUDP-HexN formed during 90 min in the 
presence of GalN and 5-F[r4C]Urd was consistently 
higher than that of FUDP-HexNAc (fig.3). The com- 
bination of GalN + 6-aza-Urd + S-FUrd resulted in a 
formation of FUDP-HexN and FUDP-HexNAc corre- 
sponding to -38% (1 .O mmoljkg cells) and 16% 
(0.42 mmol/kg ceils) of the total acid-soluble nucieo- 
tides, respectively (fig.3). 
3.3. Intracellular contents of &fluorouridine 
phosphates and incorporation into RNA 
Levels of FUTP of more than 0.5 mmollkg cells, 
far in excess over the endogeneous UTP content, were 
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Table 1 
Incorporation of5-fluoro-[‘4C]uridine 
Antipyrimidincs Total cellular Acid-soluble % total [ 14C]FUMP % total 
incorporation fraction in RNA 
(mmol/kg) (mmol/k& (mmol/kg) 
5-IWrd 0.92 i 0.06 0.80 i 0.03” 87.7 0.09 t 0.04 9.6 
6-Aza-Urd + 5-FUrd 1.60 ? 0.66 1.25 f 0.56b 78.1 0.25 i- 0.03 15.5 
GalN + 5-FUrd 1.48 i- 0.41 1.28 i 0.34 86.4 0.20 i 0.07 13.6 
GalN + 6-Aza-Urd + 5-FUrd 2.95 i 0.55 2.65 r 0.46c 89.8 0.30 i 0.12 10.2 
PALA + 5-FUrd 1.57 i 0.34 1.35 * 0.31 85.6 0.23 * 0.04 14.4 
GalN + PALA + 5-FUrd 3.96 i 0.43 3.60 * 0.35 91.1 0.35 * 0.09 9.0 
a,b,c Total acid soluble 5-FUra 5’-nucleotides determined by enzymatic analysis [20] (mmol/kg cells + SD): 
a 0.85 + 0.06; b 1.48 f 0.23;’ 2.53 + 0.13 
AS-30D cells were incubated at 1.5-2.5 X log/1 in the presence of antipyrimidines as in section 2. Cells had 
been exposed, except for controls, to 6-aza-Urd, GalN, PALA or combinations of these for 180 min when 
5-F[2-14C]Urd was added for additional 90 min. RNA was hydrolyzed by treating the washed acid-insoluble 
fraction with NaOH (0.2 mol/l) for 20 h at 37°C and counted for radioactivity in fluoro-[‘4C]uridylate. Incor- 
poration as mmol/kg wet cells was calculated from the known specific activity of 5-F[‘4C]Urd, from the 
radioactivity counted in the various fractions (700-9000 cpm), and from the cell wet weight determined 
[ 131. Mean values from 3 different experiments * SD are given 
r-cached when 5-FUrd was added to cells depleted of 
UTP (f&.1). This replenishment of the UTP pool with 
FUTP was most rapid during the initial 10 min and 
almost complete after 30 min. Two major factors 
contributed to an increased incorporation of 5-FUrd 
into the cells: a low level of UTP and the continued 
trapping of fluorouridylate by GalN. The highest 
contents of 5-F[ 14C] Urd metabolites were reached 
when an inhibitor of dc novo pyrimidine synthesis 
and GalN were combined. This result was con- 
firmed by enzymatic analysis (table 1). After 90 min, 
the uptake into the acid-soluble fraction was 
increased 4.5-fold to a level of 3.60 + 0.35 (SD) 
mmol/kg cells when the cells had been pretreated 
with GalN + PALA (table 1). Under this condition 
94% were phosphorylated derivatives of 5-FUrd and 
the content of FUTP amounted to 0.79 mmol/kg. 
The higher uptakes of 5-FUrd into the cells were 
paralleled by an increased incorporation of fluoro- 
uridylate in RNA (table 1). 
4. Discussion 
S-FUrd is one of the substrates of uridine kinase 
[22]. This enzyme is under feedback control by UTP 
and other pyrimidinc nucleoside 5’-triphosphates 
including FUTP [2] . Induction of selective UTP 
deficiency and adjustment of different UTP levels in 
ascites hepatoma cells [4,16] led us to demonstrate 
the inverse relationship between 5-F [ 14C] Urd uptake 
and UTP concentration in intact cells (fig.2). This 
result is consistent with the view that phosphoryla- 
tion rather than transport of nucleosides is the rate- 
determining step in their incorporation into the 
cellular nucleotide pool [23] . The demonstration 
of FUDP-amino sugar formation and accumulation 
in cells treated with GalN and .5-FUrd (fig.2) serves 
to understand the promoting effect of GalN on 
5-FUrd uptake (fig.3, table 1). Elevated levels of 
UDP-amino sugars are retained in the liver for many 
hours [ 191. This indicates a slow regeneration of the 
UDP moiety. Accordingly, FUDP-amino sugars may 
serve as a metabolic store of FUDP. The latter is the 
precursor of both, FdUMP, a powerful inhibitor of 
thymidytate synthetase, and FUTP that is incor- 
porated into RNA and interferes with processing and 
function of RNA (summary [ 1 ] ). It is known at 
present whether FUDP-amino sugars are utilized by 
amino sugar transferases as substrates without inter- 
fering in the reaction. In E. coli K-12, 5-fluorouracil 
produces an osmotically sensitive state associated 
with an inhibition of cell-wall synthesis and an 
accumulation of N-acetylhexosamine esters [24] . A 
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similar phenomenon, however, has not been observed 
in mammalian cells treated with fluorinated 
pyrimidines. 
Incorporation of 5-fluorouridylate into RNA was 
augmented in an additive manner when an inhibitor 
of de novo pyrimidine nucleotide synthesis was 
combined with GalN (table 1). This incorporation 
into RNA, under some conditions, appears as the key 
to the toxicity observed in Novikoff hepatoma cells 
in vitro [25] and to the chemotherapeutic effective- 
ness in experimental cancer in mice [26]. On the 
other hand, tissue retention of FdUMP and the 
associated inhibition of DNA synthesis appears as a 
major determinant in the therapeutic activity of 
Sfluorouracil [27]. 
The sequential administration of GalN, 6-aza-Urd 
(or PALA), and S-FUrd has been proposed as a 
protocol for the treatment of hepatocellular cancer 
[3,28]. A high degree of cell specificity is provided in 
this combination by GalN [3] . The accumulation 
of FUDP-amino sugars may prolong the action of 
S-FUrd and reduce the extrahepatic toxicity. 
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